Clinical Trial Update: Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine [Phase 2]

View source ↗

Summary

A Phase 2 trial of a peritoneal dialysis solution containing icodextrin, xylitol, and carnitine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Icodextrin-Xylitol-Carnitine PD Solution (Icodextrin-Xylitol-Carnitine peritoneal dialysis solution)

Snippet

Sponsor: Iperboreal Pharma Srl | Conditions: End Stage Renal Disease (ESRD) | Phase 2 | Status: WITHDRAWN